Beacon Medicare Ltd. introduced another block buster drugs Obetix for Cirrhosis Treatment
BEACON introduced a Farnesoid X Receptor agonist, Obeticholic Acid, under the brand name of Obetix for the treatment of Primary Biliary Cirrhosis .
Obetix is a general drug in oral tablet preparation available in the strength of 5 mg.
This product is only for export.
To know more visit our website: